Kentaro Masuhiro

622 total citations
22 papers, 363 citations indexed

About

Kentaro Masuhiro is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kentaro Masuhiro has authored 22 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Kentaro Masuhiro's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pregnancy and preeclampsia studies (3 papers). Kentaro Masuhiro is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pregnancy and preeclampsia studies (3 papers). Kentaro Masuhiro collaborates with scholars based in Japan and United Kingdom. Kentaro Masuhiro's co-authors include Takeshi Taniguchi, Noboru Matsuzaki, Osamu Tanizawa, Fumitaka Saji, Takayuki Shiroyama, Kenji Yone, Takashi Kameda, Atsushi Kumanogoh, Moto Yaga and Kotaro Miyake and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Kentaro Masuhiro

19 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kentaro Masuhiro Japan 9 134 91 90 80 57 22 363
Francesco Savinelli France 6 90 0.7× 103 1.1× 25 0.3× 36 0.5× 23 0.4× 13 259
Breton Roussel United States 8 82 0.6× 81 0.9× 14 0.2× 93 1.2× 32 0.6× 21 327
Nick Topley United Kingdom 7 69 0.5× 38 0.4× 60 0.7× 66 0.8× 8 0.1× 9 459
Jiashan Ding China 8 78 0.6× 143 1.6× 18 0.2× 20 0.3× 10 0.2× 13 243
Taisuke Akutsu Japan 9 106 0.8× 35 0.4× 47 0.5× 25 0.3× 15 0.3× 32 330
Yawei Wu China 5 212 1.6× 22 0.2× 60 0.7× 46 0.6× 61 1.1× 6 360
Elissa McMurtrie Canada 11 149 1.1× 25 0.3× 111 1.2× 20 0.3× 88 1.5× 15 383
Wan‐Hsiang Hu Taiwan 13 174 1.3× 51 0.6× 25 0.3× 72 0.9× 3 0.1× 23 394
Weining Xiong China 9 25 0.2× 171 1.9× 71 0.8× 212 2.6× 7 0.1× 28 500
Dong‐Seok Han South Korea 10 166 1.2× 67 0.7× 15 0.2× 524 6.5× 9 0.2× 21 713

Countries citing papers authored by Kentaro Masuhiro

Since Specialization
Citations

This map shows the geographic impact of Kentaro Masuhiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Masuhiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Masuhiro more than expected).

Fields of papers citing papers by Kentaro Masuhiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Masuhiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Masuhiro. The network helps show where Kentaro Masuhiro may publish in the future.

Co-authorship network of co-authors of Kentaro Masuhiro

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Masuhiro. A scholar is included among the top collaborators of Kentaro Masuhiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Masuhiro. Kentaro Masuhiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Satoh, S., Kotaro Miyake, Yuichi Adachi, et al.. (2024). Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition. Biochemical and Biophysical Research Communications. 696. 149511–149511. 1 indexed citations
3.
Miyake, Kotaro, Takayuki Shiroyama, Yuichi Adachi, et al.. (2024). Balloon Dilatation for Bronchoscope Delivery in a Swine Model: A Novel Technique for Ultra-Peripheral Lung Field Access and Accurate Biopsy. Respiration. 103(4). 205–213. 1 indexed citations
4.
Komukai, Sho, Tomoaki Hoshino, Kentaro Masuhiro, et al.. (2023). Identifying phenotypes in interstitial lung disease using group-based trajectory modelling. The International Journal of Tuberculosis and Lung Disease. 27(4). 332–334.
5.
Miyake, Kotaro, Izumi Nagatomo, Takayuki Shiroyama, et al.. (2022). Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing. Scientific Reports. 12(1). 19774–19774. 2 indexed citations
6.
Takeda, Yoshito, Haruhiko Hirata, Yuya Shirai, et al.. (2022). Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan. Journal of Thoracic Disease. 14(5). 1332–1341. 2 indexed citations
7.
Noda, Yoshimi, Takayuki Shiroyama, Kentaro Masuhiro, et al.. (2022). Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer. Scientific Reports. 12(1). 8881–8881. 10 indexed citations
8.
Ikuta, Shoko, et al.. (2022). Cerebral Infarction Caused by Trousseau’s Syndrome Associated With Lung Cancer. World Journal of Oncology. 13(6). 403–408.
9.
Naito, Yujiro, et al.. (2020). Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood. Journal of Visualized Experiments. 1 indexed citations
10.
Shiroyama, Takayuki, Izumi Nagatomo, Shohei Koyama, et al.. (2019). Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study. Scientific Reports. 9(1). 2447–2447. 126 indexed citations
11.
Koba, Taro, Seigo Minami, Kentaro Masuhiro, et al.. (2018). Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 82(1). 111–117. 2 indexed citations
12.
Masuhiro, Kentaro, Takayuki Shiroyama, Hidekazu Suzuki, et al.. (2018). Impact of Pleural Effusion on Outcomes of Patients Receiving Osimertinib for NSCLC HarboringEGFRT790M. Anticancer Research. 38(6). 3567–3571. 11 indexed citations
13.
Shiroyama, Takayuki, Ayako Tanaka, Kentaro Masuhiro, et al.. (2018). Transformation to small cell lung cancer after first-line afatinib treatment. Respiratory Medicine Case Reports. 23. 188–190. 10 indexed citations
14.
Suzuki, Hidekazu, Takayuki Shiroyama, Ayako Tanaka, et al.. (2018). Skin Rash Can Be a Useful Marker for Afatinib Efficacy. Anticancer Research. 38(3). 1783–1788. 6 indexed citations
15.
Shiroyama, Takayuki, Kentaro Masuhiro, Ayako Tanaka, et al.. (2018). Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations. Internal Medicine. 57(24). 3643–3645. 7 indexed citations
16.
17.
Fujimoto, Kosuke, Seigo Minami, Suguru Yamamoto, et al.. (2014). Comparison of timing and decision-makers of do-not-resuscitate orders between thoracic cancer and non-cancer respiratory disease patients dying in a Japanese acute care hospital. Supportive Care in Cancer. 22(6). 1485–1492. 12 indexed citations
18.
Minami, Seigo, Masanari Hamaguchi, Suguru Yamamoto, et al.. (2014). Small-cell lung cancer: a case report on the manifestation of paraneoplastic motor neuron disease after effective tumor shrinkage during chemotherapy. International Cancer Conference Journal. 3(4). 247–251. 1 indexed citations
19.
Kanai, Takahiro, et al.. (1997). Serum vitamin K level and bone mineral density in post‐menopausal women. International Journal of Gynecology & Obstetrics. 56(1). 25–30. 42 indexed citations
20.
Matsuzaki, Noboru, Kentaro Masuhiro, Tatsunori Jo, et al.. (1992). Trophoblast-derived transforming growth factor-beta 1 suppresses cytokine-induced, but not gonadotropin-releasing hormone-induced, release of human chorionic gonadotropin by normal human trophoblasts.. The Journal of Clinical Endocrinology & Metabolism. 74(1). 211–216. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Savinelli Breakdown of academic impact, for papers by Breton Roussel Breakdown of academic impact, for papers by Nick Topley Breakdown of academic impact, for papers by Jiashan Ding Breakdown of academic impact, for papers by Taisuke Akutsu Breakdown of academic impact, for papers by Yawei Wu Breakdown of academic impact, for papers by Elissa McMurtrie Breakdown of academic impact, for papers by Wan‐Hsiang Hu Breakdown of academic impact, for papers by Weining Xiong Breakdown of academic impact, for papers by Dong‐Seok Han
Rankless by CCL
2026